Definium Therapeutics, Inc. - Common Shares (NQ:DFTX)
22.37
-0.09
(-0.40%)
Streaming Delayed Price
Updated: 12:04 PM EDT, Apr 17, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 649,614 |
| Open | 22.86 |
| Bid (Size) | 22.35 (100) |
| Ask (Size) | 22.36 (300) |
| Prev. Close | 22.46 |
| Today's Range | 22.01 - 23.00 |
| 52wk Range | 14.62 - 23.41 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Definium (DFTX) Q4 2025 Earnings Call Transcript ↗
February 27, 2026
Definium Therapeutics to Participate at Upcoming Investor Conferences
February 24, 2026
Definium Therapeutics Announces New Employee Inducement Grants
February 02, 2026
Definium Therapeutics Appoints Roger Adsett to Board of Directors
January 29, 2026
Definium Therapeutics Announces New Employee Inducement Grants
January 26, 2026
2026 Asset Growth: Why Federal Compliance Is the New Metric
January 19, 2026
Frequently Asked Questions
Is Definium Therapeutics, Inc. - Common Shares publicly traded?
Yes, Definium Therapeutics, Inc. - Common Shares is publicly traded.
What exchange does Definium Therapeutics, Inc. - Common Shares trade on?
Definium Therapeutics, Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Definium Therapeutics, Inc. - Common Shares?
The ticker symbol for Definium Therapeutics, Inc. - Common Shares is DFTX on the Nasdaq Stock Market
What is the current price of Definium Therapeutics, Inc. - Common Shares?
The current price of Definium Therapeutics, Inc. - Common Shares is 22.37
When was Definium Therapeutics, Inc. - Common Shares last traded?
The last trade of Definium Therapeutics, Inc. - Common Shares was at 04/17/26 12:04 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.